In order to illustrate whether TILs have prognostic value in DCIS, we performed a systematic review and meta-analysis to investigate the prognostic roles of TILs and CD4+, CD8+, FOXP3+ and PD-L1 TIL subtypes in DCIS. The gene discussed is CD8A; the disease is ductal breast carcinoma in situ.